Laboratory Workup for Unexplained Hematoma and Rash
For a patient presenting with unexplained hematoma and rash, immediately order: complete blood count with platelet count and peripheral blood smear, PT/INR, aPTT, fibrinogen, von Willebrand factor testing (vWF antigen, ristocetin cofactor activity, factor VIII), and platelet function testing with light transmission aggregometry. 1, 2, 3
Initial Screening Tests
The first-line laboratory workup must establish whether you're dealing with a platelet disorder, coagulation factor deficiency, or vascular/connective tissue problem:
- Complete blood count with platelet count: Identifies thrombocytopenia as a cause; examine red cell morphology, leukocyte differential, and mean platelet volume to distinguish hypoproliferative from consumptive mechanisms 3, 4
- Peripheral blood smear: Focus on platelet count and morphology to identify inherited platelet disorders 1
- PT/INR and aPTT: These are universally supported screening tests 5
- Fibrinogen level: Part of the minimum hemostasis assay panel 2
- Thrombin time: Completes the basic coagulation screening 2, 3
Pattern Recognition for Diagnosis
The combination of PT and aPTT results directs your next steps:
- Normal PT and aPTT: Suspect a platelet disorder (most commonly von Willebrand disease) or bleeding disorder of unknown cause (BDUC) 3, 6
- Normal PT, prolonged aPTT: Indicates intrinsic pathway defect; perform mixing study to distinguish factor deficiency from inhibitor 6, 7, 8
- Prolonged PT, normal aPTT: Suggests extrinsic pathway disorder; consider vitamin K deficiency 3, 6
- Both prolonged: Workup for liver failure or combined factor deficiencies 6
Von Willebrand Disease Testing
Since normal PT/aPTT with bleeding symptoms most commonly indicates platelet dysfunction, and von Willebrand disease is the most common inherited bleeding disorder:
- vWF antigen
- Ristocetin cofactor activity
- Factor VIII activity
These must be completed before proceeding to more specialized platelet testing 1, 2
Platelet Function Assessment
If vWD is excluded but suspicion remains high, proceed with:
- Light transmission aggregometry (LTA): Initial panel should include epinephrine, ADP, collagen, arachidonic acid, and ristocetin 1
- Platelet granule release assessment: ATP/ADP assay plus at least one α-granule marker 1
- Flow cytometry on resting platelets: Antibodies against GPIIb/IIIa (CD41), GPIIIa (CD61), GPIb (CD42b), and GPIb/IX (CD42a) 1
Critical Pitfalls to Avoid
Do not miss acquired factor XIII deficiency: This presents with unexplained hematomas and completely normal routine coagulation tests (PT, aPTT, platelet count all normal). If initial workup is normal but clinical suspicion remains high, order urea clot lysis test as a screen, followed by specific factor XIII activity assay 9, 10. This is potentially life-threatening and frequently misdiagnosed.
Consider acquired hemophilia A: In patients with no prior bleeding history who present with spontaneous bleeding and isolated prolonged aPTT that doesn't correct with mixing studies, measure factor VIII activity and factor VIII inhibitor levels (Bethesda assay) 7, 8. This carries substantial mortality if missed.
Rule out nonaccidental trauma: Particularly in vulnerable populations (children, elderly, dependent adults), unexplained bruising warrants consideration of abuse 3, 11. However, always complete coagulation screening before making this diagnosis, as coagulation disorders are frequently misdiagnosed as nonaccidental trauma 11.
Use of Bleeding Assessment Tools
Employ the ISTH Bleeding Assessment Tool (BAT) to quantify bleeding severity objectively. An ISTH BAT score >6 in adults indicates 99% probability of a congenital platelet function disorder after vWD is excluded 1. However, BAT scores are less reliable in children who may have limited hemostatic challenges 1.
When to Refer to Hematology
Consult hematology immediately if:
- Initial evaluation indicates a bleeding disorder
- Suspicion remains high despite normal laboratory workup 3
- Isolated prolonged aPTT that doesn't correct with mixing studies (suggests inhibitor) 7, 8
- Unexplained hematomas with normal routine coagulation tests (consider factor XIII deficiency) 9, 10
Specialized Testing (Second-Tier)
If diagnosis remains elusive after initial workup:
- Individual clotting factor assays: To identify rare factor deficiencies 2
- Expanded LTA agonist panel: α-thrombin, TRAP-6, U46619, CRP, convulxin, PAR-4 activating peptide 1
- Transmission electron microscopy: For platelet ultrastructure 1
- Fibrinolysis assays: If delayed bleeding after primary hemostasis suggests hyperfibrinolysis 4
Genetic testing is not currently standard of care due to cost and low diagnostic yield 2.